Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics.

van Donge, Tamara; Welzel, Tatjana; Atkinson, Andrew; van den Anker, John; Pfister, Marc (2019). Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics. Journal of clinical pharmacology, 59(Suppl. 1), S21-S32. American College of Clinical Pharmacology 10.1002/jcph.1487

[img] Text
Donge_et_al-2019-The_Journal_of_Clinical_Pharmacology (1).pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Currently used creatinine-based parameters for monitoring kidney function are not reliable for early detection of kidney injury (KI), particularly tubular damage. Several KI biomarkers allow for early detection of glomerular and tubular damage and may help to prevent drug-related chronic kidney diseases in pediatrics. This literature review describes the state of current research and investigates reference values for these KI biomarkers in neonates, infants, and children to better understand age-related changes. A total of 12 of 237 screened studies fulfilled predefined criteria, including 219 preterm neonates, 70 neonates, 596 infants, and 1726 children. KI biomarkers were analyzed in urine (6 studies), in serum/plasma (5 studies) and in serum and urine (1 study). Four studies (n = 555) measured urinary kidney injury molecule-1, whereas urinary neutrophil gelatinase-associated lipocalin was assessed in 5 studies (n = 888), and 2 studies (n = 203) investigated serum cystatin C. This review of KI biomarkers in different pediatric age groups indicates that (1) the majority of KI biomarkers are measured in urine; (2) the 3 most commonly analyzed KI biomarkers are urinary neutrophil gelatinase-associated lipocalin, urinary kidney injury molecule-1, and serum cystatin C; (3) values of KI biomarkers appear to decrease from prematurity to infancy; and (4) there is an unmet need to further enhance knowledge on age-dependent changes of KI biomarkers in pediatrics. Studies are needed to better characterize reference values for these key KI biomarkers in healthy pediatric populations and to evaluate the value of these markers in the early detection of drug-related KI in neonates, infants, and children.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Atkinson, Andrew

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0091-2700

Publisher:

American College of Clinical Pharmacology

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

18 Dec 2019 15:27

Last Modified:

18 Dec 2019 15:27

Publisher DOI:

10.1002/jcph.1487

PubMed ID:

31502686

Uncontrolled Keywords:

age effect biomarkers kidney injury pediatrics reference values

BORIS DOI:

10.7892/boris.136221

URI:

https://boris.unibe.ch/id/eprint/136221

Actions (login required)

Edit item Edit item
Provide Feedback